We are live on ! Find out more
SIC

SJS Investment Consulting Portfolio holdings

AUM $919M
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+23.4%
3 Year Est. Return
+63.82%
5 Year Est. Return
10 Year Est. Return
AUM
$819M
AUM Growth
+$28.3M
Cap. Flow
+$39.9M
Cap. Flow %
4.88%
Top 10 Hldgs %
73.47%
Holding
2,597
New
508
Increased
1,194
Reduced
436
Closed
123

Sector Composition

Rank Sector Weight
1 Technology 5.03%
2 Healthcare 3.05%
3 Consumer Staples 2.87%
4 Financials 2.11%
5 Consumer Discretionary 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
151
Goldman Sachs
GS
$301B
$207K 0.03%
245
+122
+99% +$109K
IJR icon
152
iShares Core S&P Small-Cap ETF
IJR
$112B
$200K 0.02%
1,607
MRK icon
153
Merck
MRK
$322B
$198K 0.02%
1,643
-514
-24% -$59.3K
FCX icon
154
Freeport-McMoran
FCX
$98.6B
$197K 0.02%
3,354
+2,294
+216% +$139K
FITB
155
Fifth Third Bancorp
FITB
$51.7B
$194K 0.02%
4,185
+37
+0.9% +$1.82K
INTC icon
156
Intel
INTC
$498B
$187K 0.02%
4,235
+2,459
+138% +$113K
KEY icon
157
KeyCorp
KEY
$24.3B
$187K 0.02%
9,314
+91
+1% +$1.91K
TXN icon
158
Texas Instruments
TXN
$258B
$178K 0.02%
915
-6
-0.7% -$1.22K
TJX icon
159
TJX Companies
TJX
$175B
$174K 0.02%
1,091
+368
+51% +$57.3K
BMY icon
160
Bristol-Myers Squibb
BMY
$133B
$173K 0.02%
2,845
+739
+35% +$43.1K
BITO icon
161
ProShares Bitcoin Strategy ETF
BITO
$1.44B
$172K 0.02%
+18,480
New +$195K
PRF icon
162
Invesco FTSE RAFI US 1000 ETF
PRF
$10B
$172K 0.02%
3,610
+925
+34% +$45K
NHI icon
163
National Health Investors
NHI
$3.6B
$170K 0.02%
2,101
IWR icon
164
iShares Russell Mid-Cap ETF
IWR
$57.6B
$162K 0.02%
1,663
+638
+62% +$63.7K
XLV icon
165
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
$161K 0.02%
1,096
-28
-2% -$4.32K
TGT icon
166
Target
TGT
$69.5B
$160K 0.02%
1,323
-255
-16% -$28.8K
DE icon
167
Deere & Co
DE
$164B
$156K 0.02%
277
-182
-40% -$103K
NOBL icon
168
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
$154K 0.02%
2,900
+500
+21% +$27.4K
EME icon
169
Emcor
EME
$36.1B
$154K 0.02%
208
+62
+42% +$45.1K
SPSB icon
170
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.8B
$153K 0.02%
5,099
+1,070
+27% +$32.3K
JAZZ icon
171
Jazz Pharmaceuticals
JAZZ
$16.6B
$150K 0.02%
795
+38
+5% +$6.64K
MCK icon
172
McKesson
MCK
$102B
$149K 0.02%
172
+12
+8% +$10.7K
IEFA icon
173
iShares Core MSCI EAFE ETF
IEFA
$195B
$145K 0.02%
1,603
-251
-14% -$23.4K
XLF icon
174
State Street Financial Select Sector SPDR ETF
XLF
$58.9B
$145K 0.02%
2,936
-159
-5% -$8.29K
PCG icon
175
PG&E
PCG
$37.8B
$144K 0.02%
8,211
+2,355
+40% +$40.1K

Similar funds

SJS Investment Consulting's Q1 2026 Portfolio in Review

As of Q1 2026, SJS Investment Consulting held 2,597 positions worth $819M, up 3.6% from $790M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

SJS Investment Consulting deployed $39.9M of net new capital in Q1 2026, opening 508 new positions and adding to 1,194 existing holdings. Its largest new stake was Avantis Total Equity Markets ETF: 205,237 shares worth $9.65M.

By sector, the portfolio is most concentrated in Technology at 5% of assets, down from 5.6% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Apple, an estimated $1.32M trimmed.

  • SJS Investment Consulting's largest Q1 2026 buy was Avantis Total Equity Markets ETF: 205,237 shares worth $9.65M.
  • SJS Investment Consulting added most to Dimensional US Core Equity 2 ETF in Q1 2026, an estimated $4.83M increase.
  • SJS Investment Consulting's biggest Q1 2026 reduction was Apple, cutting an estimated $1.32M.
  • SJS Investment Consulting fully exited GeneDx Holdings in Q1 2026, selling an estimated $390K.
  • SJS Investment Consulting's ten largest holdings make up 73% of its $819M portfolio in Q1 2026.
  • SJS Investment Consulting opened 508 new positions and closed 123 in Q1 2026.
  • SJS Investment Consulting's portfolio value rose 3.6% quarter-over-quarter to $819M.

Based on SJS Investment Consulting's 13F filing for Q1 2026, filed 23 Apr 2026.